ADAR1 Capital Management, LLC
Filing Date
Global Rank
#1,299
/ 8,700
▲ 363
Top Industry
Biotechnology
89.9%
Period ended 2 months ago
Filed Aug 14, 2026 · 30d
11 quarters · since Dec 2023
Portfolio Concentration
260 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
11.8%
+1.8 pts
Top 5
32.5%
+3.1 pts
Top 10
43.4%
+1.9 pts
HHI
307
Diversified+36
Portfolio Trend
11 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 91.2% | $1,908,920,351 |
| Unclassified | 6.1% | $127,492,557 |
| Financial Services | 2.6% | $53,600,540 |
| Real Estate | 0.0% | $1,030,575 |
| Communication Services | 0.0% | $1,012,077 |
| Industrials | 0.0% | $777,150 |
| Consumer Cyclical | 0.0% | $598,216 |
| Technology | 0.0% | $195,000 |
| Consumer Defensive | 0.0% | $92,400 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| PLRX | Pliant Therapeutics, Inc. | +2,924,598 | 5,509,724 | $6,281,085 | |
| OVID | Ovid Therapeutics Inc. | +2,873,366 | 7,417,479 | $19,953,018 | |
| IFRX | InflaRx N.V. | +2,841,729 | 3,000,000 | $6,720,000 | |
| ENGN | enGene Therapeutics Inc. | +1,971,300 | 2,104,986 | $3,641,625 | |
| ZLAB | Zai Lab Ltd | +1,943,667 | 3,369,034 | $64,011,646 | |
| YARW | Yarrow Bioscience, Inc. | +1,886,101 | 2,950,000 | $1,920,450 | |
| ALEC | Alector, Inc. | +1,833,583 | 2,883,583 | $5,796,001 | |
| FULC | Fulcrum Therapeutics, Inc. | +1,434,469 | 1,565,029 | $5,728,006 | |
| IVA | Inventiva S.A. | +1,432,258 | 3,606,656 | $13,633,159 | |
| ENTA | Enanta Pharmaceuticals Inc | +1,293,153 | 1,344,510 | $19,602,955 | |
| WHWK | Whitehawk Therapeutics, Inc. | +1,212,891 | 1,341,394 | $6,143,584 | |
| AGIO | Agios Pharmaceuticals, Inc. | +1,147,381 | 1,288,053 | $47,799,646 | |
| ZURA | Zura Bio Ltd | +1,128,892 | 1,759,295 | $10,379,840 | |
| PEPG | PepGen Inc. | +983,447 | 2,591,085 | $4,663,953 | |
| RLYB | Rallybio Corp | +905,817 | 926,352 | $14,821,632 | |
| ANL | Adlai Nortye Group Ltd. | +899,896 | 1,017,805 | $11,704,757 | |
| IKT | Inhibikase Therapeutics, Inc. | +780,633 | 7,387,205 | $14,996,026 | |
| PRLD | Prelude Therapeutics Inc | +748,075 | 900,900 | $4,801,797 | |
| INO | Inovio Pharmaceuticals, Inc. | +673,802 | 2,143,910 | $2,358,301 | |
| ZNTL | Zentalis Pharmaceuticals, Inc. | +508,114 | 652,750 | $3,165,837 | |
| SRPT | Sarepta Therapeutics, Inc. | +468,591 | 730,649 | $13,129,762 | |
| CATX | Perspective Therapeutics, Inc. | +460,782 | 1,210,117 | $4,126,498 | |
| BHVN | Biohaven Ltd. | +456,910 | 501,687 | $7,465,102 | |
| TRAW | Traws Pharma, Inc. | +443,631 | 597,729 | $502,092 | |
| ABVX | Abivax S.A. | +411,084 | 1,849,103 | $246,411,465 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| ABUS | Arbutus Biopharma Corp | −1,865,028 | 1,268,147 | $6,087,105 | |
| REPL | Replimune Group, Inc. | −1,027,203 | 655,784 | $7,259,528 | |
| DNLI | Denali Therapeutics Inc. | −842,375 | 1,029,080 | $26,467,937 | |
| SPRY | ARS Pharmaceuticals, Inc. | −760,537 | 600,999 | $4,814,001 | |
| AVR | Anteris Technologies Global Corp. | −644,036 | 3,145,096 | $30,979,195 | |
| PALI | Palisade Bio, Inc. | −538,183 | 1,726,662 | $3,608,723 | |
| DBVT | DBV Technologies S.A. | −484,571 | 528,295 | $8,664,038 | |
| AMLX | Amylyx Pharmaceuticals, Inc. | −466,126 | 534,478 | $9,599,224 | |
| MLTX | MoonLake Immunotherapeutics | −450,137 | 27,000 | $525,690 | |
| VTGN | Vistagen Therapeutics, Inc. | −400,000 | 351,141 | $80,762 | |
| MPLT | MapLight Therapeutics, Inc. | −348,412 | 26,497 | $949,652 | |
| IMVT | Immunovant, Inc. | −348,294 | 2,330,716 | $89,802,487 | |
| ELDN | Eledon Pharmaceuticals, Inc. | −326,609 | 647,812 | $2,552,379 | |
| VIR | Vir Biotechnology, Inc. | −288,037 | 2,456,677 | $25,033,538 | |
| SNY | Sanofi | −259,839 | 57,100 | $2,435,886 | |
| OKUR | OnKure Therapeutics, Inc. | −196,257 | 2,238,684 | $10,208,399 | |
| CYTK | Cytokinetics Inc | −174,649 | 457,907 | $39,009,097 | |
| AEXA | American Exceptionalism Acquisition Corp. A | −152,131 | 205,408 | $2,427,922 | |
| SEPN | Septerna, Inc. | −149,071 | 940,747 | $31,505,617 | |
| URGN | UroGen Pharma Ltd. | −143,064 | 252,395 | $9,288,136 | |
| ROIV | Roivant Sciences Ltd. | −128,898 | 3,157,008 | $111,726,513 | |
| STRO | Sutro Biopharma, Inc. | −120,427 | 404,014 | $13,413,264 | |
| PCVX | Vaxcyte, Inc. | −113,103 | 146,034 | $8,488,956 | |
| IBIO | iBio, Inc. | −94,347 | 375,531 | $657,179 | |
| LGVN | Longeveron Inc. | −91,594 | 108,406 | $76,209 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
25 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| EDIT | Editas Medicine, Inc. | 8,889,000 | $28,800,360 | |
| VOR | Vor Biopharma Inc. | 680,626 | $12,530,324 | |
| FTH | Faeth Therapeutics, Inc. | 361,010 | $9,025,250 | |
| AMAN | Amanat Acquisition Corp. | 750,000 | $7,620,000 | |
| RACC | Research Alliance Corp III | 650,000 | $6,955,000 | |
| RLAY | Relay Therapeutics, Inc. | 358,333 | $6,704,410 | |
| BOLD | Boundless Bio, Inc. | 1,968,216 | $4,920,540 | |
| AVLN | Avalyn Pharma Inc. | 146,447 | $4,821,035 | |
| JATT | JATT II Acquisition Corp. | 417,724 | $4,745,344 | |
| RNTX | Rein Therapeutics, Inc. | 4,500,000 | $4,680,000 | |
| APGE | Apogee Therapeutics, Inc. | 31,000 | $4,114,630 | |
| SGMT | Sagimet Biosciences Inc. | 437,500 | $3,381,875 | |
| CUE | Cue Biopharma, Inc. | 55,193 | $1,741,891 | |
| TRAX | First Tracks Biotherapeutics, Inc. | 71,910 | $1,446,829 | |
| INM | InMed Pharmaceuticals Inc. | 800,000 | $1,240,000 | |
| ARTV | Artiva Biotherapeutics, Inc. | 118,624 | $1,150,652 | |
| ALXO | Alx Oncology Holdings Inc | 533,660 | $1,104,676 | |
| RNAC | Cartesian Therapeutics, Inc. | 98,877 | $1,030,298 | |
| CYCN | Korsana Biosciences, Inc. | 298,757 | $1,012,786 | |
| ACAD | Acadia Pharmaceuticals Inc | 38,955 | $985,561 | |
| GPCR | Structure Therapeutics Inc. | 17,500 | $939,225 | |
| AURA | Aura Biosciences, Inc. | 130,152 | $924,079 | |
| CCXI | Churchill Capital Corp XI | 50,000 | $872,500 | |
| KZIA | Kazia Therapeutics Ltd | 61,550 | $866,624 | |
| SYK | Stryker Corp | 2,000 | $629,680 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
25 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| AAAA | Amplius Aggressive Asset Allocation ETF | 337,125 | $39,204,266 | |
| BEAM | Beam Therapeutics Inc. | 1,446,375 | $34,467,116 | |
| SRRK | Scholar Rock Holding Corp | 407,273 | $20,021,540 | |
| AAXJ | iShares MSCI All Country Asia ex Japan ETF | 27,500 | $6,820,000 | |
| VRTX | Vertex Pharmaceuticals Inc / Ma | 15,075 | $6,731,590 | |
| VRDN | Viridian Therapeutics, Inc.\DE | 304,422 | $5,954,494 | |
| LLY | ELI LILLY & Co | 5,060 | $4,654,036 | |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | 55,000 | $4,615,600 | |
| BLTE | Belite Bio, Inc | 26,880 | $4,285,747 | |
| LQDA | Liquidia Corp | 100,000 | $3,774,000 | |
| AVBP | ArriVent BioPharma, Inc. | 141,814 | $3,271,648 | |
| TFX | Teleflex Inc | 21,186 | $2,534,057 | |
| BIOA | BioAge Labs, Inc. | 135,560 | $2,370,944 | |
| BWX | State Street SPDR Bloomberg International Treasury Bond ETF | 15,000 | $1,915,950 | |
| KPTI | Karyopharm Therapeutics Inc. | 341,936 | $1,904,583 | |
| ALKS | Alkermes plc. | 46,400 | $1,640,704 | |
| UNH | Unitedhealth Group Inc | 5,501 | $1,488,515 | |
| SXT | Sensient Technologies Corp | 15,000 | $1,296,600 | |
| SDGR | Schrodinger, Inc. | 101,500 | $1,153,040 | |
| FDMT | 4D Molecular Therapeutics, Inc. | 116,712 | $1,086,588 | |
| BMY | Bristol Myers Squibb Co | 17,500 | $1,061,375 | |
| GH | Guardant Health, Inc. | 10,000 | $923,700 | |
| ITGR | Integer Holdings Corp | 8,750 | $770,000 | |
| CGEM | Cullinan Therapeutics, Inc. | 50,000 | $710,500 | |
| GUTS | Fractyl Health, Inc. | 1,428,571 | $654,285 | |
| No positions match the current search. | ||||
260 tracked positions ·
$2,093,718,866 total
· filing declares
277 positions · $2,185,183,006
· as of Jun 30, 2026
All sectors
Communication Services
Consumer Cyclical
Consumer Defensive
Financial Services
Healthcare
Industrials
Real Estate
Technology
Showing 1–50
of 260 positions by value
· page 1 of 6
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| ABVX |
Abivax S.A.
CALL
+ SHARES
Healthcare
|
Added | 1,849,103 | $246,411,465 | 11.77% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
Reduced | 960,863 | $117,782,586 | 5.63% | |
| SPY |
Spdr S&P 500 ETF Trust
PUT
+ SHARES
|
Added | 154,087 | $115,067,548 | 5.50% | |
| ROIV |
Roivant Sciences Ltd.
Healthcare
|
Reduced | 3,157,008 | $111,726,513 | 5.34% | |
| IMVT |
Immunovant, Inc.
Healthcare
|
Reduced | 2,330,716 | $89,802,487 | 4.29% | |
| ZLAB |
Zai Lab Ltd
Healthcare
|
Added | 3,369,034 | $64,011,646 | 3.06% | |
| AGIO |
Agios Pharmaceuticals, Inc.
Healthcare
|
Added | 1,288,053 | $47,799,646 | 2.28% | |
| CRNX |
Crinetics Pharmaceuticals, Inc.
Healthcare
|
Added | 1,222,080 | $45,730,233 | 2.18% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
Reduced | 457,907 | $39,009,097 | 1.86% | |
| SEPN |
Septerna, Inc.
Healthcare
|
Reduced | 940,747 | $31,505,617 | 1.50% | |
| AVR |
Anteris Technologies Global Corp.
Healthcare
|
Reduced | 3,145,096 | $30,979,195 | 1.48% | |
| EDIT |
Editas Medicine, Inc.
Healthcare
|
NEW | 8,889,000 | $28,800,360 | 1.38% | |
| DNLI |
Denali Therapeutics Inc.
Healthcare
|
Reduced | 1,029,080 | $26,467,937 | 1.26% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
Reduced | 283,982 | $25,211,921 | 1.20% | |
| VIR |
Vir Biotechnology, Inc.
Healthcare
|
Reduced | 2,456,677 | $25,033,538 | 1.20% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Added | 74,253 | $24,859,161 | 1.19% | |
| INSM |
INSMED Inc
Healthcare
|
Added | 228,520 | $24,364,802 | 1.16% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
Added | 619,542 | $23,053,157 | 1.10% | |
| VKTX |
Viking Therapeutics, Inc.
Healthcare
|
Added | 574,038 | $22,393,222 | 1.07% | |
| TSHA |
Taysha Gene Therapies, Inc.
Healthcare
|
Added | 3,040,466 | $20,705,573 | 0.99% | |
| MNPR |
Monopar Therapeutics
Healthcare
|
Reduced | 217,595 | $20,147,121 | 0.96% | |
| OVID |
Ovid Therapeutics Inc.
Healthcare
|
Added | 7,417,479 | $19,953,018 | 0.95% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
Added | 387,718 | $19,676,688 | 0.94% | |
| ENTA |
Enanta Pharmaceuticals Inc
Healthcare
|
Added | 1,344,510 | $19,602,955 | 0.94% | |
| NKTR |
Nektar Therapeutics
Healthcare
|
Added | 244,184 | $17,046,485 | 0.81% | |
| INSP |
Inspire Medical Systems, Inc.
Healthcare
|
Reduced | 374,617 | $16,711,664 | 0.80% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Reduced | 87,509 | $16,388,685 | 0.78% | |
| ESTA |
Establishment Labs Holdings Inc.
Healthcare
|
Reduced | 185,619 | $15,927,966 | 0.76% | |
| PRTA |
Prothena Corp Public Ltd Co
Healthcare
|
Reduced | 1,554,535 | $15,218,897 | 0.73% | |
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
Reduced | 136,158 | $15,117,622 | 0.72% | |
| IKT |
Inhibikase Therapeutics, Inc.
Healthcare
|
Added | 7,387,205 | $14,996,026 | 0.72% | |
| QURE |
uniQure N.V.
Healthcare
|
Added | 324,672 | $14,954,392 | 0.71% | |
| RLYB |
Rallybio Corp
Healthcare
|
Added | 926,352 | $14,821,632 | 0.71% | |
| REGN |
Regeneron Pharmaceuticals, Inc.
Healthcare
|
Added | 22,208 | $13,847,576 | 0.66% | |
| IVA |
Inventiva S.A.
Healthcare
|
Added | 3,606,656 | $13,633,159 | 0.65% | |
| STRO |
Sutro Biopharma, Inc.
Healthcare
|
Reduced | 404,014 | $13,413,264 | 0.64% | |
| IONS |
Ionis Pharmaceuticals Inc
Healthcare
|
Added | 166,286 | $13,184,816 | 0.63% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
Added | 176,689 | $13,159,796 | 0.63% | |
| SRPT |
Sarepta Therapeutics, Inc.
Healthcare
|
Added | 730,649 | $13,129,762 | 0.63% | |
| CTMX |
CytomX Therapeutics, Inc.
Healthcare
|
Reduced | 3,365,118 | $12,619,192 | 0.60% | |
| VOR |
Vor Biopharma Inc.
Healthcare
|
NEW | 680,626 | $12,530,324 | 0.60% | |
|
|
Held | 135,585 | $12,425,009 | 0.59% | ||
| EQ |
Equillium, Inc.
Healthcare
|
Added | 3,758,569 | $12,027,420 | 0.57% | |
| ANL |
Adlai Nortye Group Ltd.
Healthcare
|
Added | 1,017,805 | $11,704,757 | 0.56% | |
| CLYM |
Climb Bio, Inc.
Healthcare
|
Added | 822,649 | $10,727,342 | 0.51% | |
| HLXC |
Helix Acquisition Corp. III
Financial Services
|
Held | 1,000,000 | $10,640,000 | 0.51% | |
| ZURA |
Zura Bio Ltd
Healthcare
|
Added | 1,759,295 | $10,379,840 | 0.50% | |
| OKUR |
OnKure Therapeutics, Inc.
Healthcare
|
Reduced | 2,238,684 | $10,208,399 | 0.49% | |
| MAZE |
Maze Therapeutics, Inc.
Healthcare
|
Added | 339,276 | $10,123,995 | 0.48% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Reduced | 166,550 | $10,052,958 | 0.48% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.